- AstraZeneca PLC press release (AZN): Q3 Non-GAAP EPS of $2.79.
- Revenue of $16.21B (+6.7% Y/Y) beats by $210M.
- FY2026 Guidance AstraZeneca reconfirms: Total Revenue is expected to increase by a mid-to-high single-digit percentage.
- Core EPS is expected to increase
